Relx Plc $RELX Shares Bought by Janney Montgomery Scott LLC

Key Points

• Janney Montgomery Scott LLC significantly increased its holdings in Relx Plc by 304.6% in the 2nd quarter, now owning 242,649 shares valued at approximately $13.19 million.
• Relx recently announced a cut in its semi-annual dividend, issuing a dividend of $0.2634, which reflects a yield of 170.0%.
• While the stock is currently rated with a consensus of "Buy," there have been mixed analyst opinions, with some upgrades and downgrades affecting its valuation.

Janney Montgomery Scott LLC boosted its holdings in shares of Relx Plc (NYSE:RELX - Free Report) by 304.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 242,649 shares of the technology company's stock after acquiring an additional 182,673 shares during the quarter. Janney Montgomery Scott LLC's holdings in Relx were worth $13,186,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Larson Financial Group LLC increased its stake in Relx by 612.5% during the first quarter. Larson Financial Group LLC now owns 513 shares of the technology company's stock worth $26,000 after acquiring an additional 441 shares during the last quarter. WPG Advisers LLC acquired a new stake in Relx during the first quarter worth $28,000. Golden State Wealth Management LLC increased its stake in Relx by 100.0% during the first quarter. Golden State Wealth Management LLC now owns 588 shares of the technology company's stock worth $30,000 after acquiring an additional 294 shares during the last quarter. Cornerstone Planning Group LLC increased its stake in Relx by 325.2% during the first quarter. Cornerstone Planning Group LLC now owns 693 shares of the technology company's stock worth $37,000 after acquiring an additional 530 shares during the last quarter. Finally, UMB Bank n.a. increased its stake in Relx by 19.1% during the second quarter. UMB Bank n.a. now owns 1,634 shares of the technology company's stock worth $89,000 after acquiring an additional 262 shares during the last quarter. Institutional investors and hedge funds own 15.02% of the company's stock.

Relx Stock Down 0.4%

Shares of NYSE RELX opened at $46.43 on Friday. The company has a market capitalization of $85.09 billion, a price-to-earnings ratio of 24.96, a price-to-earnings-growth ratio of 3.04 and a beta of 0.87. The company has a debt-to-equity ratio of 2.55, a current ratio of 0.47 and a quick ratio of 0.42. The business has a 50-day moving average of $47.85 and a two-hundred day moving average of $50.95. Relx Plc has a 1 year low of $44.19 and a 1 year high of $56.33.

Relx Cuts Dividend

The company also recently announced a semi-annual dividend, which was paid on Tuesday, September 16th. Stockholders of record on Friday, August 8th were issued a $0.2634 dividend. This represents a dividend yield of 170.0%. The ex-dividend date of this dividend was Friday, August 8th. Relx's payout ratio is presently 27.96%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Kepler Capital Markets raised Relx from a "hold" rating to a "strong-buy" rating in a research note on Thursday, September 18th. Wall Street Zen cut Relx from a "buy" rating to a "hold" rating in a research note on Friday, September 5th. Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a research note on Thursday, September 11th. Finally, Weiss Ratings reaffirmed a "buy (b)" rating on shares of Relx in a research note on Saturday, September 27th. One research analyst has rated the stock with a Strong Buy rating and five have assigned a Buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Buy".

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.